SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-275622
Filing Date
2018-09-18
Accepted
2018-09-17 22:01:26
Documents
4
Effectiveness Date
2018-09-18

Document Format Files

Seq Description Document Type Size
1 S-8 d623766ds8.htm S-8 64788
2 EX-5.1 d623766dex51.htm EX-5.1 7628
3 EX-23.1 d623766dex231.htm EX-23.1 1915
4 GRAPHIC g623766g64w41.jpg GRAPHIC 7244
  Complete submission text file 0001193125-18-275622.txt   85368
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-227389 | Film No.: 181074539
SIC: 2834 Pharmaceutical Preparations